Publication | Closed Access

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

OncologyGastrointestinal OncologyMedicinePathologyCancer TreatmentPharmacologyRadiation OncologyGastrointestinal TractLung CancerCancer ResearchNon-functional Neuroendocrine Tumours